Clinical Trial Update: Prevention of Progression of Prediabetes, Obesity and CV Risk [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating prevention of progression of prediabetes, obesity, and cardiovascular risk; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Obesity
• Prediabetes

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Pre-Diabetes, Weight, Body | Phase 1 | Status: RECRUITING